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ABSTRACT
Human induced pluripotent stem cells (iPSCs) can be differentiated into vascular endothelial (iEC)
and smooth muscle (iSMC) cells. However, because iECs and iSMCs are not derived from an intact
blood vessel, they represent an immature phenotype. Hemodynamics and heterotypic cell:cell com-
munication play important roles in vascular cell phenotypic modulation. Here we tested the hypoth-
esis that hemodynamic exposure of iECs in coculture with iSMCs induces an in vivo-like phenotype.
iECs and iSMCs were cocultured under vascular region-speciﬁc blood ﬂow hemodynamics, and com-
pared to hemodynamic cocultures of blood vessel-derived endothelial (pEC) and smooth muscle
(pSMC) cells. Hemodynamic ﬂow-induced gene expression positively correlated between pECs and
iECs as well as pSMCs and iSMCs. While endothelial nitric oxide synthase 3 protein was lower in
iECs than pECs, iECs were functionally mature as seen by acetylated-low-density lipoprotein (LDL)
uptake. SMC contractile protein markers were also positively correlated between pSMCs and iSMCs.
Exposure of iECs and pECs to atheroprone hemodynamics with oxidized-LDL induced an inﬂamma-
tory response in both. Dysfunction of the transforming growth factor b (TGFb) pathway is seen in
several vascular diseases, and iECs and iSMCs exhibited a transcriptomic prolife similar to pECs and
pSMCs, respectively, in their responses to LY2109761-mediated transforming growth factor b recep-
tor I/II (TGFbRI/II) inhibition. Although there are differences between ECs and SMCs derived from
iPSCs versus blood vessels, hemodynamic coculture restores a high degree of similarity in their
responses to pathological stimuli associated with vascular diseases. Thus, iPSC-derived vascular cells
exposed to hemodynamics may provide a viable system for modeling rare vascular diseases and
testing new therapeutic approaches. STEM CELLS TRANSLATIONAL MEDICINE 2017;6:1673–1683
SIGNIFICANCE STATEMENT
Human induced pluripotent stem cells (iPSCs) can be differentiated into vascular endothelial
and smooth muscle cells. Hemodynamic exposure of these differentiated cells cocultured
together restores normal and pathological biological responses. Thus, we demonstrate that
iPSC-derived vascular cells exposed to hemodynamics may provide a viable system for modeling
rare vascular diseases and testing new therapeutic approaches.
INTRODUCTION
Vascular diseases of genetic origin are often difﬁ-
cult to study in the human tissue given limitations
in human sample availability and accurate model-
ing of the disease of interest. However, recent
advances in human stem cell biology are paving
the way for availability of new resources to create
powerful model systems of human diseases.
Induced pluripotent stem cells (iPSCs) have
the potential to differentiate into various adult
human cell types and tissues. iPSCs are derived
from reprogrammed human somatic cells and
exhibit an embryonic stem cell (ESC)-like pheno-
type. iPSCs hold great potential as promising tools
in developmental biology and regenerative medi-
cine, in particular for applications for reproducible
differentiation into human tissues for various
human clinical applications [1]. Furthermore, iPSC
lines produced from patients with genetic dis-
eases offer the ability to investigate speciﬁc
genetic alterations of interest and their effect in
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PLURIPOTENT STEM CELLS
Although many studies have demonstrated differentiation of
iPSCs into various cell types, the demonstration of the cells’ func-
tional mimicry to their modeled tissue and subsequent disease
application remains poor [3]. Thus, we sought to characterize the
ﬁdelity and functionality of iPSCs differentiated into vascular
endothelial (iEC) and smooth muscle (iSMC) cells for vascular tis-
sue modeling and disease characterization. Herein, we assessed
human iECs and iSMCs cocultured under vascular region-speciﬁc
blood ﬂow hemodynamics to determine if they display similar
transcriptomic and functional responses to cocultures of primary
human endothelial (pEC) and smooth muscle (pSMC) cells
exposed to the same hemodynamics.We have previously demon-
strated that this human vascular surrogate system utilizing cocul-
tures of pEC:pSMC exposed to relevant hemodynamics mimics
the in vivo endothelial and smooth muscle architecture, biology
and physiology of the blood vessel wall, and is highly responsive
to changes in hemodynamics, inﬂammatory milieu, and drug
treatments [4–6]. Our results indicate that iPSC-derived vascular
cells exhibit an immature phenotype and that hemodynamic
coculture of iEC:iSMC restores a high degree of similarity to that
of pEC:pSMC. Application of the hemodynamic coculture model
could provide a viable system for modeling rare vascular diseases
using patient-derived iPSCs to develop and test new therapeutic
approaches.
MATERIALS AND METHODS
Cell Isolation and Culture
Primary endothelial cells (pECs) and smooth muscles cells (pSMCs)
of human aortic origin were purchased from Lonza, USA, lonza.
com, and maintained in EGM-2 BulletKit (Lonza CC-3162) and
SmGM-2 BulletKit (Lonza CC-3182) media, respectively. iPSC-
derived human vascular endothelial cells (iECs; iCell Endothelial
Cells) were purchased from Cellular Dynamics International, WI,
cellulardynamics.com (ECC-100–010-001) and thawed and main-
tained according to manufacturer’s instructions using “iEC Growth
Media” (VascuLife VEGF Endothelial Medium from LifeLine Cell
Technology, MD, llifelinecelltech.com (LL-0003) and iCell Endothe-
lial Cells Medium Supplement from Cellular Dynamics (ECM-100-
030-001)). iPSC neural crest-derived human smooth muscle cells
(iSMCs) were produced at the University of Cambridge. Human
iPSCs were ﬁrst induced to form neuroectoderm under chemically
deﬁned conditions as previously described [7]. Cells were then
passaged up to 12 times to generate neural crest-like cells (Ser-
rano et al., manuscript in preparation) and induced to iSMCs using
PDGF-BB and TGFb1 [7]. iSMCs were then switched to iSMC
media (DMEM/F12 with 10% FBS, 2.5 mM glutamine, and 100 U/
ml penicillin/streptomycin) which was used for further mainte-
nance and culture.
Transwell Coculture Plating Conditions and
Hemodynamic Exposure
The transwell coculture plating and hemodynamic ﬂow device
setup is explained in detail in [4] and Figure 1A. In brief, a porous
polycarbonate 75-mm transwell membrane (Corning Inc., NY,
corning.com) was coated with 0.1% gelatin on the top and bottom
surface of the membrane. Human pSMCs or iSMCs were plated
on the bottom transwell surface in their respective maintenance
medium. After 2 days, human pECs or iECs were plated on the top
transwell surface in ﬂow media (see below) or iEC growth media,
respectively, and incubated overnight. Transwells plated with cells
were placed in ﬂow media containing reduced serum (M199 sup-
plemented with 2% FBS, 2 mM L-glutamine, and 100 U/ml penicil-
lin-streptomycin) for ﬂow experiments.
The cocultured ECs and SMCs were then exposed to physio-
logically relevant hemodynamics utilizing a direct drive cone-and-
plate viscometer described in [4]. Brieﬂy, this system contains a
base that securely holds the 75-mm transwell containing cells and
a cone that ﬁts into the transwell compartment. Hemodynamic
ﬂow was imparted by the rotating cone to the EC layer of the EC-
SMC coculture transwell setup. The velocity waveforms imparted
by the cone are generated by a drive system using a microstepper
motor (Axis New England, MA, axisne.com) controlled by software
that allows programmable speciﬁed hemodynamics (Motion Plan-
ner, Parker Compumoter). Human hemodynamic shear stress pro-
ﬁles and blood velocity proﬁles were derived from the human
common carotid artery (CCA) and internal carotid sinus (ICS),
areas of atheroprotective/healthy regions or areas prone to ather-
osclerosis (atheroprone; Fig. 1B) and calculated as previously
described in [8, 9]. In-ﬂow and out-ﬂow tubing accessing the inner
and outer chambers of the transwell allow for continual perfusion
of media to both the EC and SMC layers. Flow media was pre-
pared with dextran to obtain the desired viscosity necessary for
transmitting physiological human waveform shear forces from
motor/cone assembly to the cells.
Normal and Pathological Hemodynamic Conditions and
Drug Treatments
In the ﬁrst set of experiments, human primary and iPSC-derived
vascular cells were exposed to atheroprotective (CCA) or athero-
prone (ICS) hemodynamics or kept in static culture for 48 hours.
In a second set of experiments, after human primary and
iPSC-derived vascular cells were exposed to atheroprone hemody-
namics for 18 hours, cells were exposed to native low-density lipo-
protein (nLDL, 50 lg/ml) or oxidized-LDL (oxLDL, 50 lg/ml) plus
human recombinant tumor necrosis factor-a (TNFa; 0.05 ng/ml;
R&D Systems, MN, rndsystems.com, 210-TA-010) in the athero-
prone condition for an additional 30 hours. The addition of nLDL
to atheroprone hemodynamics mimics baseline atheroprone con-
ditions while oxLDL and TNFa in the atheroprone state mimics
advanced inﬂammatory conditions (AIC) in the context of cardio-
vascular disease. Human nLDL was purchased from Kalen Biomedi-
cal, MD, kalenbiomed.com (770200). nLDL was oxidized via the
following protocol: nLDL was dialyzed overnight in PBS to remove
EDTA. Next, nLDL was dialyzed in PBS containing 13.8 lM CuSO4
for three days to oxidize the LDL. Following completion of oxida-
tion, LDL was dialyzed in PBS containing 50 lM EDTA to remove
excess Cu. Electrophoretic migration of oxLDL versus nLDL pro-
vides a measure of the oxidative state of LDL.
In the ﬁnal set of experiments, cells exposed to baseline athe-
roprone hemodynamics were treated with vehicle control
(dimethyl sulfoxide [DMSO]) or the TGFb inhibitor, LY2109761, at
the 24-hour time point for an additional 24 hours. LY2109761 was
prepared in DMSO and diluted 1:1,000 in the experiment to
achieve a ﬁnal experimental concentration of 15lM.
RNA Preparation and RNA Deep Sequencing
EC and SMC cell pellets were collected and RNA isolated using the
Invitrogen Purelink RNA Mini kit (12183018A) according to manu-
facturer’s instructions (CA, thermoﬁsher.com). RNA concentration
was determined with the Nanodrop and RNA integrity was
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determined using the Agilent 2100 Bioanalyzer and the Agilent
RNA 6000 kit (5067-1511) according to manufacturer’s instruc-
tions (CA, agilent.com). Samples with a minimum RNA Integrity
Number 7.0 were used for further transcriptomics processing. 250
ng RNA per sample was submitted to Expression Analysis, Inc., A
Quintiles Company, NC, q2labsolutions.com, for Illumina-based
RNA deep sequencing. Approximately 20 million 50 base paired-
end reads were generated per sample. For each treatment, the
following samples were processed for RNA Seq: n5 3 for iEC and
iSMC samples (all same donor) and n5 4 for pEC and pSMC sam-
ples (each different donor).
Data Analysis and Statistics
Following RNA deep sequencing, reads were aligned to a standard
hg19 human transcriptome. Alignment was done using Bowtie
0.12.9 with the ﬁnal gene counts calculated using eXpress v1.5.1
[10, 11]. Three RNA deep sequencing quality control measure-
ments were performed to detect outliers and batch effects associ-
ated with the data set: (a) false color heatmaps of distance
between samples, (b) principal component analyses, and (c) over-
lapping density estimates. After evaluating these quality control
outputs, outliers were excluded and batch effects, which consisted
of donor variability, removed.
The RNA deep sequencing data set counts was then analyzed
to determine differentially expressed genes (DEGs). Methods for
DEG determination were implemented using the open source R/
BioConductor software (http://www.bioconductor.org) and the
edgeR package [12], with only genes that passed our threshold
(more than 2 counts per million in at least 3 human samples, the
minimum number of biological replicates) being used for further
analysis. A gene was determined to be a DEG by passing an FDR
threshold of 10% (using the Benjamini and Hochberg FDR correc-
tion [13]). Select genes of relevant biological processes were cho-
sen to build response heatmaps that depict changes in gene
expression based on a log2fold scale of 22 to 2: blue5 downre-
gulation, red5 upregulation, white5 no change; the intensity of
the color reﬂects the magnitude of change; a white dot indicates a
statistically signiﬁcant change in the expression of the correspond-
ing gene (FDR< 10%). Limma-calculated fold-changes (log base 2
transformed), raw null hypothesis testing p values, and Benjamini-
Hochberg adjusted false discovery rates (FDR) were used as input
for downstream pathway analyses with ingenuity pathway analysis
(IPA), signaling pathway impact analysis (SPIA), top gene ontology
(topGO), and gene set enrichment analysis (GSEA) pathway enrich-
ment algorithms, which included known pathway gene lists from
KEGG, Reactome, Biocarta, and Gene Ontology databases [14–21].
Pathways found enriched for responses with a FDR signiﬁcance of
20% or better are kept for consideration; redundant pathway
enrichments are identiﬁed and merged based on strongly con-
nected pathway-to-pathway gene overlaps, using the Louvain
method55 for graph-based community clustering [22].
When comparing two conditions with each other, we calcu-
lated the response similarity index (RSI). The RSI was calculated
for each gene and determines the degree to which the two
Figure 1. Application of iPSC-derived or primary endothelial cells (ECs) and smooth muscle cells (SMCs) to the human vascular surrogate
system. (A): Normal vascular wall shear stress proﬁles were applied to the human vascular surrogate system using a cone-and-plate viscome-
ter incorporated into a transwell coculture model of ECs (green cells) and SMCs (red cells). Rotation of the cone (orange triangle) imparts
downward directional shear stress onto the ECs. Media is continually perfused to recapitulate interstitial ﬂow, as indicated by the inﬂow and
outﬂow ports. (B): Blood velocity proﬁles were obtained by magnetic resonance imaging from the human CCA and the ICS regions. (C): Repre-
sentative photomicrographs of iECs and iSMCs exposed to hemodynamics from the common carotid arterial region are shown. Green5 phal-
loidin; blue5 TO-PRO-3. Scale bar5 100 lm. (D): RNA was collected from pECs and pSMCs as well as iECs and iSMCs cocultured,
respectively, in static conditions or exposed to CCA hemodynamics. Transcriptomic data was then plotted along two principal component
axes to determine overall similarities and differences between samples. Abbreviations: CCA, common carotid artery; ECA, external carotid
artery; ICS, internal carotid sinus; iECs, iPSC-derived ECs; iSMCs, iPSC-derived SMCs; pECs, primary ECs; pSMCs, primary SMCs.
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conditions alter gene expression in the same (RSI> 0.5, purple
dots) or opposite (RSI<20.5, green dots) manner. If two condi-
tions stimulate identical responses, all the data would fall on the
identity line of a gene-by-gene scatterplot.
As described in [23], a global protein–protein interaction (PPI)
network, derived from publicly available high-conﬁdence interac-
tions deﬁned by the STRING database was used for overlaying our
transcriptomic data [24]. The goal of the protein-gene network is
to identify centers of dysregulation in response to drug treatment.
Connections between nodes were determined by evidence of
functional protein-protein interactions (as deﬁned by STRING).
Edges were weighted by the probability that their incident nodes
were differentially expressed. Connections with low weight were
ﬁltered, substantially reducing the number of proteins in the net-
work; the resulting network of interactions reﬂects the strongest
evidence of regulation. The size of any given node is proportional
to its weighted connectivity and the weighted connectivity of its
neighbors, thus, node size is an indicator of the relative impor-
tance of each node. Protein communities, comprised of more
densely connected nodes, likely represent coordinated biological
activities that contribute to similar signaling pathways.
Confocal Microscopy
ECs and SMCs plated on transwells and exposed to hemodynamics
were ﬁxed in 4% paraformaldehyde for 10 minutes, permeabilized
in 0.2% triton X-100 in PBS for 5 minutes, and incubated with pri-
mary antibody for 2 hours at room temperature. After three
washes in PBS, they were incubated with secondary antibodies for
1 hour at room temperature. Anti-human primary antibodies
against eNOS (BD Biosciences, CA, bdbiosciences.com, 610297),
calponin 1 (Sigma C2887), smooth muscle alpha actin (Sigma, USA,
sigmaaldrich.com, C6198), and SM22 (Abcam, MA, abcam.com,
ab14106) were used. Goat anti-mouse or goat anti-rabbit conju-
gated to Alexa Fluor 488 or 546 (Life Technologies, CA, thermo-
ﬁsher.com: A11001, A11003, A11008, A11010) were used as
secondary antibodies. Actin was stained with Alexa 488-phalloidin
(Life technologies, A12379). Nuclei were stained with TO-PRO-3
(Life Technologies T3605) or DRAQ 5 (Cell Signaling Technology,
MA, cellsignal.com, 4084L). ECs were also stained with the lectin,
Ulex europeaus agglutinin (UEA-1; Vector Lab, CA, vectorlabs.com,
FL-1061). Uptake of acetylated-LDL (AcLDL) was performed by
incubating ECs in 10 lg/ml ﬂuorescent Dil-acetylated-LDL (Kalen
770231–9) for 4 hours at 378C and subsequently ﬁxed as described
above. Fluorescence images of immunoﬂuorescent-labeled cells
were acquired with a Nikon 20X, 0.5 numerical aperture objective
lens on a Nikon C1 confocal microscope with EZ-C1 v3.9 software.
RESULTS
Phenotypic Characterization of iEC:iSMC Coculture in
Healthy Hemodynamics
The human vascular surrogate system applies human-derived
blood shear stress patterns to a transwell vascular coculture of
endothelial and smooth muscle cells (Fig. 1A). Applied blood
velocity proﬁles were previously obtained by magnetic reso-
nance imaging from the human CCA and the ICS regions, where
it is clear that the latter proﬁle exhibits a lower time-averaged
shear stress and reduced magnitude of pulsatility (Fig. 1B) [8].
These measurements correlate with vascular regions that exhibit
atheroprotective and atheroprone phenotypes, respectively [9].
Atherosclerotic lesions develop primarily at these atheroprone
regions of disturbed blood ﬂow characterized by low time-
averaged and oscillatory wall shear stress, often in bifurcated
areas or regions of high curvature [25]. The wall shear stress pro-
ﬁles are then applied to the human vascular system by way of a
cone-and-plate viscometer that is incorporated into the endo-
thelial and smooth muscle cell transwell coculture setup (Fig.
1A) [4, 5]. Cocultures of vascular endothelial (iEC) and smooth
muscle (iSMC) cells differentiated from human iPSCs (see Mate-
rials and Methods for cell derivation) were compared to cocul-
tures of primary human endothelial (pEC) and smooth muscle
cells (pSMC) in this human vascular surrogate system [4, 5]. We
have shown previously that pECs align with atheroprotective
(CCA) ﬂow direction and pSMCs align perpendicularly to this
ﬂow, similar to that observed in in vivo vessel organization [4].
iECs and iSMCs retained this phenotypic alignment to atheropro-
tective (CCA) hemodynamics (Fig. 1C).
Following a 48-hour exposure to CCA hemodynamics or static
conditions, cells were collected for RNA sequencing analysis of
global transcriptomics. Principal component analysis revealed a
clear separation of EC and SMC transcriptomic signal, as expected
(Fig. 1D). Interestingly, iECs separated from pECs and iSMCs sepa-
rated from pSMCs, indicating that global gene expression in iPSC-
derived vascular cells differ from primary vascular cells (Fig. 1D).
Within each cell type, cells in hemodynamic coculture clustered
together. However, the impact of the cell type was greater than
the impact of applied hemodynamics (Fig. 1D).
More detailed analysis of similarities in gene expression fold-
change and directionality was performed for ECs and SMCs of pri-
mary and iPSC origin. First, a scatterplot representation of DEGs in
endothelial cells comparing pECs to iECs in hemodynamic cocul-
ture with pSMCs or iSMCs, respectively, is depicted (Fig. 2A). Each
point represents a log2fold-change of a DEG for each cell type in
hemodynamic versus static control cocultures. A DEG with the
same directionality in fold-change for both cell types is repre-
sented in purple, while a DEG exhibiting opposite directionality is
represented in green. The color intensity increases with statistical
signiﬁcance. The RSI value is a single numerical value that incorpo-
rates the fold-change and signiﬁcance for each DEG in both cell
types. Most of the EC DEGs changed in the same direction
(RSI> 0); the ratio of DEGS with an RSI> 0 (syn DEGs with similar
response) to DEGs with an RSI< 0 (anti DEGs with opposing
response) was 5:1 (Fig. 2A, Supporting Information Fig. 1). To fur-
ther investigate biological pathways associated with DEGs regu-
lated in hemodynamic- or static-cocultured pECs and iECs, a
pathway-weighting approach was applied and several biological
themes emerged from the RSI analysis (see Materials and Meth-
ods). Similarly-regulated biological themes include extracellular
matrix (ECM) organization and cell migration signaling, while
oppositely regulated biological themes include apoptosis signaling
and calcium homeostasis (Fig. 2B).
We further characterized hemodynamic effects known to be
imparted on human vascular endothelial cells. A panel of endothe-
lial cell shear stress response genes was assessed in the presence
or absence of hemodynamic ﬂow. Established endothelial cell
markers, such as platelet/endothelial cell adhesion molecule 1
(PECAM1), endoglin (ENG), vascular endothelial cadherin (CDH5),
and kinase insert domain receptor (KDR) [26–29], remained
unchanged in iECs but were downregulated in pEC hemodynamic
compared to static cocultures (Fig. 2C). Genes important in pro-
moting vascular endothelial tone, such as endothelial nitric oxide
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synthase 3 (eNOS encoded by NOS3), kruppel-like factor 2 (KLF2),
kruppel-like factor 4 (KLF4), and argininosuccinate synthase 1
(ASS1), were upregulated by hemodynamics in both iECs and pECs
(Fig. 2C). eNOS generates nitric oxide (NO), which is a potent vaso-
dilator with strong inhibitory effects of platelet and monocyte acti-
vation and sustains vascular health by promoting anti-thrombotic
and anti-inﬂammatory effects. The KLF2 and KLF4 transcription
factors can positively regulate eNOS expression [30, 31]. Notably
the vasoconstrictor, endothelin 1 (EDN1), was downregulated in
both cell types by hemodynamics (Fig. 2C). However, levels of
gene expression markers for vascular tone were lower in iECs (Fig.
2D), which may impact vascular health and intercellular EC and
SMC communication [32–34]. This transcriptomic data was corro-
borated by real-time polymerase chain reaction (RT-PCR) of select
EC genes, such as NOS3 and KLF2 (Supporting Information Fig.
2A). Finally, inﬂammatory genes were downregulated in iECs by
hemodynamics, which also had lower baseline of expression than
primary cells (Fig. 2C, 2D) [35].
Consistent with gene expression, eNOS protein levels were
lower in iECs than pECs by immunoﬂuorescence imaging (Fig.
2E). Functional endothelial cells are characterized by their abil-
ity to scavenge acetylated-low-density lipoprotein (AcLDL) and
bind the lectin, Ulex europaeus agglutinin-1 (UEA-1) [36, 37].
Both iECs and pECs exposed to hemodynamics exhibited similar
uptake of AcLDL, while greater UEA-1 binding occurred in pECs
(Fig. 2E). Overall, analysis of shear stress activation of endothe-
lial gene markers exhibited similar, but not identical, responses
in iECs and pECs.
As above, we performed similar assessments of DEGs compar-
ing pSMCs to iSMCs in hemodynamic versus static cocultured with
pECs or iECs. RSI analysis revealed that most of the SMC DEGs
changed in the same direction (RSI> 0); the ratio of syn:anti DEGs
was 5:1 (Fig. 3A, Supporting Information Fig. 1). Furthermore, sev-
eral biological themes emerged from the RSI analysis. Similarly-
regulated biological themes include inﬂammation and hypoxia sig-
naling (via HIF1a), while oppositely regulated themes include
SMC contraction and ECM (Fig. 3A).
The quiescent, contractile phenotype of SMCs is characteristic
of a healthy vascular wall and exhibits expression of key SMC-
speciﬁc markers [38, 39]. Hemodynamic coculture exhibited
Figure 2. Phenotypic characterization of iECs and pECs in hemodynamic cocultures. iECs and pECs were cocultured with iSMCs and pSMCs,
respectively, and exposed to CCA hemodynamics or static conditions. (A): Scatterplot representation of DEGs in pECs and iECs. Each point rep-
resents DEG log2fold-change for each cell type in hemodynamic coculture versus cell-type-matched static control coculture. A purple DEG
exhibits the same directionality in fold-change for both cell types, while a green DEG exhibits opposite directionality; color intensity increases
with statistical signiﬁcance. The response similarity index (RSI) value is a single numerical value that incorporates the fold-change and signiﬁ-
cance for each DEG in both cell types. (B): A pathway-weighting approach identiﬁed several biological themes that emerged from the RSI
analysis. DEGs with similar and opposite responses are weighted to determine membership of each DEG into predominant biological themes
that are color-coded (green, blue, or red); corresponding color-coded DEGs are grouped to show membership to that theme. (C): Gene
expression for pECs and iECs of key endothelial and inﬂammatory markers are represented as log2fold-change of CCA hemodynamics versus
static (red5 upregulation, blue5 downregulation). (D): Transcriptomic data for pECs and iECs exposed to CCA hemodynamics of key endo-
thelial and inﬂammatory markers are represented as total CPM for each gene. (E): Representative photomicrographs of iECs and pECs
exposed to CCA hemodynamics: eNOS (red—left panels), acetylated-LDL (AcLDL; red—mid panels), Ulex europeaus agglutinin (UEA1; green—
right panels), and TO-PRO-3 for nuclei (blue—all panels). Scale bar5 100 lm. Abbreviations: AcLDL, acetylated-low-density lipoprotein; CCA,
common carotid artery; CPM, counts per million; DEGs, differentially expressed genes; ECM, extracellular matrix; eNOS, endothelial nitric
oxide synthase 3; iECs, iPSC-derived ECs; pECs, primary ECs; UEA1, Ulex europeaus agglutinin.
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signiﬁcant upregulation of SMC markers only in pSMCs (Fig. 3B), a
result conﬁrmed by RT-PCR of the SMC marker, ACTA2 (Supporting
Information Fig. 2A). This differing response conﬁrms the oppo-
sitely regulated biological pathway detected for SMC contraction
(Fig. 3A). This lack of response to hemodynamics may be a conse-
quence of low iEC expression of key ﬂow-regulated molecules,
such as eNOS, which is important for EC-SMC communication (Fig.
2C, 2D) [34]. Nevertheless, the iSMCs overall expressed similar lev-
els of SMC contractile markers as pSMCs, suggesting the iSMCs are
phenotypically mature (Fig. 3C, Supporting Information Fig. 2A).
Interestingly, iSMCs express greater levels of the myocardin
(MYOCD) gene than pSMCs; MYOCD is a master regulator of the
SMC contractile phenotype as it drives expression of many key
SMC contractile markers [40]. Furthermore, iSMCs exhibit upregu-
lation and increased levels of myosin heavy chain 11 (MYH11), a
highly speciﬁc marker of the SMC contractile phenotype and late
stage SMC differentiation [38]. Immunoﬂuorescence imaging of
SMC contractile markers, calponin and transgelin (SM22), provided
conﬁrmation of protein expression of key SMC markers and overall
similarity in expression levels between iSMCs and pSMCs (Fig. 3D).
Figure 3. Phenotypic characterization of iSMCs and pSMCs in hemodynamic cocultures. iECs and pECs were cocultured with iSMCs and
pSMCs, respectively, and exposed to CCA hemodynamics or static conditions. (A): Scatterplot representation of differentially expressed genes
(DEGs) in pSMCs and iSMCs. Each point represents log2fold-change of a DEG for each cell type in hemodynamic coculture versus cell-type-
matched static control coculture. A purple DEG exhibits the same directionality in fold-change for both cell types, while a green DEG exhibits
opposite directionality; color intensity increases with statistical signiﬁcance. The response similarity index (RSI) value is a single numerical
value that incorporates the fold-change and signiﬁcance for each DEG in both cell types. A pathway-weighting approach also identiﬁed sev-
eral biological themes that emerged from the RSI analysis. (B): Gene expression for pSMCs and iSMCs of contractile SMC markers are repre-
sented as log2fold-change of CCA hemodynamics versus static (red5 upregulation, blue5 downregulation). (C): Transcriptomic data for
pSMCs and iSMCs exposed to CCA hemodynamics of contractile SMC markers are also represented as total CPM for each gene. (D): Represen-
tative photomicrographs of iSMCs and pSMCs exposed to CCA hemodynamics and stained with F-actin (green—left panels), smooth muscle
alpha actin (SMAA; red—left panels), calponin (green – mid panels), transgelin (SM22; red—left panels), and TO-PRO-3 for nuclei (blue—all
panels). Scale bar5 100 lm. Abbreviations: CCA, common carotid artery; CPM, counts per million; iSMCs, iPSC-derived SMCs; pSMCs, pri-
mary SMCs; SMAA, smooth muscle alpha actin.
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Phenotypic Characterization of iEC:iSMC Coculture in
Disease-Promoting Hemodynamics
We have previously demonstrated that exposure of atheroprone
hemodynamics to the endothelium of our EC:SMC coculture leads
to cellular phenotypic modulation, promoting reduced EC and
SMC differentiation and an inﬂamed endothelium [4, 6].We com-
pared cocultures of iEC:iSMC to pEC:pSMC to determine if cells of
iPSC origin maintain this atheroprone-mediated response. Focus-
ing on the endothelium response of atheroprone (ICS) compared
to atheroprotective (CCA), RSI analysis revealed that most of the
iEC and pEC DEGs changed in the same direction (RSI> 0); the
ratio of syn:anti DEGs was 8:1 (Fig. 4A, Supporting Information
Fig. 1). Analysis of these DEGs revealed similarly-regulated path-
ways, such as inﬂammation, while oppositely-regulated pathways
include endothelial development (Fig. 4A).
Consistent with previous observations in pECs, iECs exhibited
a reduced expression of vascular tone-speciﬁc endothelial
markers, such as NOS3, KLF2, ASS1, and increased expression of
EDN1 (Fig. 4B). This transcriptomic data was corroborated by RT-
PCR of select EC genes, such as NOS3 and KLF2 (Supporting Infor-
mation Fig. 2A). However, other key endothelial markers, such as
PECAM1, CDH5, and KDR were only decreased in iECs (Fig. 4B).
Furthermore, iSMCs, but not pSMCs, exhibited a trend for
enhanced expression of SMC contractile markers (e.g., smooth
muscle alpha actin 2 (ACTA2), transgelin (TAGLN), TAGLN2, caldes-
mon 1 (CALD1), calponin 1 (CNN1), MYH11, cysteine and glycine-
rich protein 2 (CSRP2)) when exposed to atheroprone hemody-
namics (Fig. 4C, Supporting Information Fig. 2A).
Modeling Advanced-Inflammatory Conditions in the
iEC:iSMC Hemodynamic Coculture
Exposure of the endothelium to atheroprone hemodynamics pro-
motes inﬂammation, monocyte transmigration and differentiation,
and ensuing atherosclerosis [26, 41]. Key components of this
inﬂammatory milieu that predispose this region to develop athero-
sclerosis include oxLDL and TNFa. We have previously shown that
addition of oxLDL and TNFa to pEC:pEMC cocultures exposed to
atheroprone hemodynamics mimics the AIC of atherogenesis [6].
We exposed iEC:iSMC cocultures to AIC (ICS hemodynamics plus
oxLDL and TNFa) to determine if vascular cells of iPSC origin
respond similarly to primary cells. RSI analysis of pEC versus iEC and
pSMC verus pSMC cocultures in AIC compared to baseline athero-
prone (ICS hemodynamics plus native LDL [nLDL]) revealed very
similar DEG responses that fell within inﬂammation-speciﬁc biologi-
cal pathways (Fig. 5A, 5B; syn:anti DEGs ratio was 15:1 for ECs and
14:1 for SMCs, Supporting Information Fig. 1).We further character-
ized speciﬁc gene responses that make up the Cytokine-Cytokine
Receptor Interaction KEGG pathway to assess induction of inﬂam-
mation (Fig. 5C).We observed that all cell types exhibited an overall
induction of these genes in this panel (Fig. 5C). While the overall
response is highly similar, the magnitude of response differed. pECs
exhibited a greater pro-inﬂammatory response than iECs, while
iSMCs exhibited a greater pro-inﬂammatory response than pSMCs
(Fig. 5C). This transcriptomic data for inﬂammation was corrobo-
rated in ECs and SMCs by RT-PCR of select pro-inﬂammatory genes,
such as IL8 and CCL2 (Supporting Information Fig. 2B). Oxidative
stress is an important determinant in the initiation and progression
of atherosclerosis [42]. Thus, analysis of the gene response for the
NRF2-Mediated Oxidative Stress IPA pathway revealed that most
genes in this pathway are upregulated in response to AIC and are
regulated quite similarly in all cell types (Fig. 5D).
Modeling Dysregulation of the TGFb Pathway in
iEC:iSMC Hemodynamic Coculture
iPSCs represent a way to test genetic variants in a more physiolog-
ical system. One such biology relates to the TGFb pathway, which
is involved in many diseases such as cancer, heart disease, Marfan
syndrome, Loeys-Deitz syndrome, and others [43]. Thus we
wanted to test the robustness of iEC:iSMC cocultures to respond
similarly to pEC:pSMC cocultures in the context of a disease state.
iEC:iSMC and pEC:pSMC cocultures exposed to baseline athero-
prone hemodynamics (ICS hemodynamics plus nLDL) were treated
Figure 4. Phenotypic characterization of iPSC-derived and primary
ECs and SMCs in cocultures exposed to atheroprone hemodynamics.
iECs and pECs were cocultured with iSMCs and pSMCs, respectively,
and exposed to atheroprone (ICS) or atheroprotective (CCA) hemody-
namics. (A): Scatterplot representation of differentially expressed
genes (DEGs) in pECs and iECs. Each point represents log2fold-change
of a DEG for each cell type in CCA versus ICS hemodynamic coculture.
A purple DEG exhibits the same directionality in fold-change for both
cell types, while a green DEG exhibits opposite directionality; color
intensity increases with statistical signiﬁcance. The RSI value is a sin-
gle numerical value that incorporates the fold-change and signiﬁ-
cance for each DEG in both cell types. A pathway-weighting approach
also identiﬁed several biological themes that emerged from the RSI
analysis. (B): Gene expression for pECs and iECs of key endothelial
and inﬂammatory markers are represented as log2fold-change of
CCA versus ICS hemodynamics (red5 upregulation, blue5 downre-
gulation). (C): Gene expression for pSMCs and iSMCs of contractile
SMC markers are represented as log2fold-change of CCA versus ICS
hemodynamics (red5 upregulation, blue5 downregulation). Abbre-
viations: CCA, common carotid artery; iECs, iPSC-derived ECs; ICS,
internal carotid sinus; iSMCs, iPSC-derived SMCs; pSMCs, primary
SMCs; pECs, primary ECs; RSI, response similarity index.
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with either vehicle control or the TGFb inhibitor, LY2109761, at 15
lM. pEC versus iEC and pSMC versus pSMC were highly similar in
their response, with few opposing changes in gene expression
(Fig. 6A, 6B; syn:anti DEGs ratio was 11:1 for both ECs and SMCs,
Supporting Information Fig. 1). Furthermore, protein-protein
interaction networks determined from gene overlay expression
data revealed several large hubs of biological communities in the
SMCs (Fig. 6C; see Materials and Methods). These communities
include biological pathways for TGFb signaling, ECM remodeling,
and inﬂammation, indicating that the TGFb inhibitor, LY2109761,
achieved on-target effects (Fig. 6C). Gene expression analysis of
the TGFb Signaling Reactome/NCI pathway revealed an overall
suppression of genes of this pathway in all cell types by
LY2109761 (Fig. 6D). Speciﬁcally, LY2109761 inhibited both
TGFbR1-(ACVRL1/ALK1 and TGFBR1/ALK5) and TGFbRII-mediated
signaling pathways in all cell types as evidenced by downregula-
tion of most genes in this signaling cascade (Fig. 6E) [44]. This tran-
scriptomic data for TGFb signaling was corroborated in SMCs and
ECs by RT-PCR of select pro-inﬂammatory genes, such as FN1 and
COL1A1 (Supporting Information Fig. 2C).
DISCUSSION
While many studies demonstrate the utility of iECs and iSMCs for
vascular applications [45–58], no studies to date provide a direct
comparison of primary to iPSC-derived ECs and SMCs nor do they
recapitulate the in vivo cellular architecture and environment of
the vascular tissue characteristic of heterotypic cell-cell interac-
tions. The only study to date that evaluates iEC phenotypic
response to ﬂow does so without direct comparison to its primary
cell counterpart [45]. Herein, we demonstrate that exposure of
iEC:iSMC cocultures in a human vascular surrogate system recapit-
ulates many aspects of the phenotypic response observed in
pEC:pSMC hemodynamic cocultures. iECs maintained endothelial-
speciﬁc functional responses, such as AcLDL uptake and UEA-1
binding, while iSMCs exhibited expression of key SMC contractile
markers. Even more so, these iEC:iSMC hemodynamic cocultures
respond very strongly and similarly to primary cells in this system
when exposed to AIC and drug treatments. Thus, while iEC:iSMC
hemodynamic cocultures exhibit some differences in response to
normal physiological hemodynamics, these cells respond very well
to pathological stimuli and thus may be used to model atheroscle-
rosis or other diseases where no primary cells exist or are chal-
lenging to resource, such as Marfan syndrome or GACI
(generalized arterial calciﬁcation in infants) [59, 60].
As mentioned, some differences in phenotypic responses
were observed between iPSCs and the corresponding primary
cells when cocultured and exposed to normal physiological hemo-
dynamics. Baseline differences in EC and SMC marker expression
may account for phenotypic responses by atheroprotective ﬂow.
While EC markers decreased with ﬂow in pECs and SMC markers
increased with ﬂow in pSMCs with minimal changes in the iPSC-
Figure 5. Modeling AIC in iEC:iSMC hemodynamic cocultures. iECs and pECs were cocultured with iSMCs and pSMCs, respectively, and
exposed to atheroprone (ICS) hemodynamics in the presence of 50 lg/ml human-derived oxLDL1 0.05 ng/ml TNFa to mimic AIC or in the
presence of 50 lg/ml human-derived nLDL to mimic baseline atheroprone conditions. (A, B): Scatterplot representation of differentially
expressed genes (DEGs) in pECs and iECs or pSMCs and iSMCs. Each point represents log2fold-change of a DEG for each cell type in AIC versus
baseline atheroprone hemodynamic coculture. A purple DEG exhibits the same directionality in fold-change for both cell types, while a green
DEG exhibits opposite directionality; color intensity increases with statistical signiﬁcance. The response similarity index (RSI) value is a single
numerical value that incorporates the fold-change and signiﬁcance for each DEG in both cell types. A pathway-weighting approach also identi-
ﬁed several biological themes that emerged from the RSI analysis. (C): Heatmap representing the expression proﬁle of genes for the
Cytokine-Cytokine Receptor Interaction KEGG pathway is represented for ECs and SMCs as log2fold-change of AIC versus baseline athero-
prone (red5 upregulation, blue5 downregulation). (D): Heatmap representing the expression proﬁle of genes for the NRF2-Mediated Oxida-
tive Stress IPA pathway is represented for ECs and SMCs as log2fold-change of AIC versus baseline atheroprone (red5 upregulation,
blue5 downregulation). Abbreviations: AIC, advanced inﬂammatory conditions; iECs, iPSC-derived ECs; iSMCs, iPSC-derived SMCs; pECs, pri-
mary ECs; pSMCs, primary SMCs; TNFa, tumor necrosis factor-a.
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derived cells (Figs. 2 and 3), the total expression counts for these
genes in both the primary and iPSC-derived cells were similar. Fur-
thermore, baseline expression of inﬂammatory genes in iECs was
lower than in pECs exposed to ﬂow (Fig. 2C, 2D). Since primary
cells exhibit a greater modulation of gene expression upon hemo-
dynamic exposure to restore their normal differentiated pheno-
type, it can only be speculated that primary cells passaged in
static culture exhibit greater loss of its regional phenotype com-
pared to using iPSC-derived cells.
To account for differences in primary versus iPSC-derived cells,
anti-gene responses and their associated biological pathways
were assessed and revealed key differences in an unbiased man-
ner. For example, apoptosis signaling and calcium homeostasis
pathways exhibit opposing signaling in pECs and iECs (Fig. 2B). An
increase in apoptosis in pECs or iECs warrants attention as this
may indicate a higher degree of unwanted cell stress. Further-
more, calcium signaling is important for various endothelial cell
functions, such as NO signaling [33]. Indeed, we observed that
iECs exhibit lower levels of the NO-producing gene, NOS3, and its
protein, eNOS (Fig. 2), which could account for differences in
calcium signaling and intercellular communication between ECs
and SMCs [32–34]. In fact, loss of NO signaling can increase cal-
cium signaling in SMCs and promote loss of the contractile SMC
phenotype. Indeed, intracellular calcium signaling is a critical
mediator of SMC phenotypic modulation [61, 62]. Thus, low eNOS
levels in iECs may account for lack of induction of SMC marker
expression by atheroprotective ﬂow in iSMCs.
Baseline epigenetic variation in iPSC-derived versus primary
cells may be attributable to embryological origin of the primary
cells. It has been suggested that embryonic lineage of SMCs
may affect disease onset and progression [39, 63]. In this study,
we utilized primary vascular cells of aortic origin, a region that
is highly susceptible to atherosclerosis and aortic aneurysms
[64]. Thus, primary cells of this origin may be predisposed to a
disease-like phenotype. The use of iPSC-derived vascular cells
may circumvent this problem by emulating a virgin vascular cell
that has not been preconditioned to external pathological
stimuli.
We also demonstrated that iPSC-derived ECs and SMCs can be
used to model diseases and responses to drug treatments. Marfan
Figure 6. Modeling dysregulation of the TGFb pathway in iEC:iSMC hemodynamic cocultures. iECs and pECs were cocultured with iSMCs and
pSMCs, respectively, and exposed to atheroprone (ICS) hemodynamics in the presence of 50 lg/ml human-derived nLDL and treated with vehi-
cle control (DMSO) or the TGFb inhibitor, LY2109761, at 15 lM. (A, B): Scatterplot representation of differentially expressed genes (DEGs) in
pECs and iECs or pSMCs and iSMCs. Each point represents log2fold-change of a DEG for each cell type in LY2109761 versus baseline athero-
prone hemodynamic coculture. A purple DEG exhibits the same directionality in fold-change for both cell types, while a green DEG exhibits
opposite directionality; color intensity increases with statistical signiﬁcance. The response similarity index (RSI) value is a single numerical value
that incorporates the fold-change and signiﬁcance for each DEG in both cell types. A pathway-weighting approach also identiﬁed several biolog-
ical themes that emerged from the RSI analysis. (C): Gene expression data for pSMCs and iSMCS was overlayed onto protein-protein interaction
networks to reveal hubs of potentially regulated biological communities. Speciﬁc communities relevant to TGFb signaling, including ECM orga-
nization, are highlighted by boxes. These communities for iSMCs are magniﬁed to reveal inclusion of speciﬁc DEGs. (D, E): Heatmaps represent-
ing the expression proﬁle of all genes for the TGFb Signaling Reactome/NCI pathway (D) and select genes of this pathway (E) are represented
for ECs and SMCs as log2fold-change of LY2109761 versus baseline atheroprone (red5 upregulation, blue5 downregulation). Abbreviations:
ECM, extracellular matrix; iECs, iPSC-derived ECs; iSMCs, iPSC-derived SMCs; pECs, primary ECs; pSMCs, primary SMCs.
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syndrome is a rare autosomal dominant disorder caused by muta-
tions in ﬁbrillin-1 (FBN1), resulting in pleiotropic manifestations
including connective tissue remodeling and the development of
aortic aneurysms. The molecular basis for disease in this condition
is still debated but abnormalities in TGFb signaling have been
observed as a consequence of FBN1 mutations. We have recently
shown roles for both deregulation of TGFb signaling and abnormal
mechano-sensing in disease development in Marfan syndrome
using patient-derived iPSC-SMCs [65]. Blockade of different com-
ponents of TGFb signaling partially rescued some aspects of the
disease phenotype in iSMCs although more complex cocultures
were not studied. Our present ﬁndings show that treatment of
iEC:iSMC and pEC:pSMC cocultures exposed to disease hemody-
namics with the TGFbR1/II inhibitor, LY2109761, was able to
inhibit TGFb signaling similarly in all cells, and validate this more
physiological coculture system for further investigations of the
Marfan iPSC-based disease model.
The seminal ﬁnding that adult somatic cells can be reprog-
rammed by the ectopic expression of a distinct repertoire of fac-
tors and then differentiated into a variety of somatic cell types
paved the way for new advances in disease modeling, drug
screening, and cell-based therapies [1, 66]. This has enormous
implications as adult stem cells of increasing donor age or primary
cells have limited proliferation and differentiation capabilities. Fur-
thermore, the use of iPSC versus embryonic stem cells (ESCs) cir-
cumvents ethical issues surrounding ESCs. In fact, studies have
demonstrated that iPSCs exhibit minimal transcriptome variance
to ESCs, increasing the likelihood of successful disease modeling
with iPSC sources [58]. Finally, as we have recently demonstrated,
the generation of patient-speciﬁc iPSCs creates a powerful model
where both the disease-causing mutation and the permissive
genetic background for that disease phenotype can be captured
and harnessed for further studies [65]. If these patient-derived
iPSC-based assays could lend themselves to high throughput
screens, then this can enable personalization of new drug devel-
opment and drug toxicity testing as vascular toxicity is a signiﬁcant
impediment to drug development.
CONCLUSION
We demonstrate that cocultures of iPSC-derived ECs and SMCs
display a high degree of similarity in response to hemodynamics
as observed with primary EC:SMC cocultures. This ﬁnding opens
up new possibilities for modeling rare diseases with patient-
derived iPSCs, screening new drugs, and developing personalized
cell-based therapies.
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